FMS 株価分析 — Fresenius Medical Care Corporation (Healthcare >> Medical Care Facilities)
FMS に関するよくある質問
FMSのPER(株価収益率)は?
Fresenius Medical Care Corporation(FMS)は現在PER 14.59倍で取引されています。
FMSのROE(自己資本利益率)は?
Fresenius Medical Care CorporationのROEは7.13%です。
FMSの配当利回りは?
Fresenius Medical Care Corporationの配当利回りは3.40%です。
FMSの品質スコア(Quality Score)は?
当社のAIはFMSの総合財務品質を100点中62点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
FMSは今が買い時ですか?
当社AIのタイミングスコアは100点中89点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
FMSはどのセクターに属しますか?
Fresenius Medical Care CorporationはHealthcare >> Medical Care Facilitiesセクターに分類されます(NYSE市場)
FMS AI Analysis Summary
Our AI summary for FMS: Fresenius Medical Care Corporation (NYSE), Healthcare >> Medical Care Facilities sector. The stock currently trades at a P/E of 14.59, ROE of 7.13%, a dividend yield of 3.40%. Its financial Quality Score stands at 62/100 — mid-range fundamentals relative to the market. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 25.26
Price
-0.40
(-1.56%)
Day Change
|
|
|---|
FMS, ファンダメンタルスコアはok ( ファンダメンタル = 62) そして テクニカルスコアは ...(Sign In to See)...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROEが低い
平均ROEが低い
ROAがROEに比べて低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
54% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 96 |
| Magic Formula Rank by ROA |
1558
|
| Magic Formula Rank by ROE |
1558
|
| Magic Formula Rank by ROIC |
1506
|
| Price | 25.26 |
| PBV / Sector |
0.97 / 2.66
GREAT
|
| Earning Per Share | 1.73 |
| PE / Sector |
14.59 / 22.93
|
| PEG or PE/Growth / Sector |
0.31 / 0.98
GOOD
|
| Average 1M Daily Value |
14.06 M
GREAT
|
| Average 1W Daily Value |
22.21 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
50% |
| ポイントになる統計 |
|
58% |
| 配当 |
|
33% |
| 登録情報 |
| Analyze Date | 2026-08-04 08:01:32 |
| Symbol | FMS |
| Name | FRESENIUS MEDICAL CARE CORPORATION |
| Sector | Healthcare >> Medical Care Facilities |
| Market | NYSE |
| Listed Shares | 537.13 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 13,782.74 / 7,056.32 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Else-Kröner-Strasse 1, Bad Homburg, Germany, 61352
Phone: 49 6172 609 0
Website: https://www.freseniusmedicalcare.com
Employees: 108,165
Description: Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Care Facilities
Click a bubble to view stock details · Bubble size represents market capitalization share
Google